Results 121 to 130 of about 15,196 (172)

Monitoring high-risk patients for chemotherapy-related cardiotoxicity: A retrospective analysis. [PDF]

World J Clin Cases
Méndez-Toro A, Muñoz-Rossi FA, Tejada-Cabrera RE, Rojas-Ruiz IT, Flechas-Ardila JD, García-Gutiérrez A, Novoa-Álvarez RA.   +6 more
europepmc   +1 more source

Effectiveness of Frequently Used TNF Inhibitors vs. Conventional Immunosuppressive Therapies for Noninfectious Uveitis. [PDF]

Ocul Immunol Inflamm
Gangaputra SS, Newcomb CW, Ying GS, Dreger KA, Fitzgerald T, Artornsombudh P, Kothari S, Liesegang TL, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Levy-Clarke GA, Lowder CY, Goldstein DA, Holland GN, Jaffe GJ, Davis JL, Acharya NR, Latkany PA, Read RW, Garg SJ, Liederman YI, Buchanich JM, Kempen JH, For The Systemic Immunosuppressive Therapy For Eye Diseases Site Cohort Study Research Group.   +28 more
europepmc   +1 more source

Skeletal muscle index, grip strength, and physical performance as predictors of severe chemotherapy toxicity among older adults with malignancy. [PDF]

PLoS One
Papadopoulos E, Rozenberg D, Wong AKO, Law SHC, Costa S, Cheung AM, Alibhai SMH.   +6 more
europepmc   +1 more source

Update on Therapy for Non-Infectious Scleritis. [PDF]

Clin Ophthalmol
Richey A, Sattarova V, Kopplin LJ, Armbrust KR.   +3 more
europepmc   +1 more source

Adalimumab versus Conventional Immunosuppression for Uveitis (ADVISE) Trial. [PDF]

Ophthalmology
Adalimumab versus Conventional Immunosuppression for Uveitis Trial Research Group, Jabs DA, Sugar EA, Burke AE, Altaweel M, Thorne JE, Baksh S, Lim L, Thomas A, Yeh S, Holbrook JT.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Antimetabolites

Current Opinion in Oncology, 1992
Research efforts over the past year further elucidate the determinants of sensitivity and mechanisms of resistance to the antimetabolites fluorouracil, methotrexate, and cytarabine. Progress has been made in clarifying the complex regulation of target enzyme expression for these antimetabolites.
A P, Chen, J L, Grem
openaire   +4 more sources

Antimetabolite Radiosensitizers

Journal of Clinical Oncology, 2007
Radiosensitization with antimetabolites has improved clinical outcome for patients with solid malignancies, especially cancers of the GI tract, cervix, and head and neck. Fluorouracil (FU) and hydroxyurea have been widely used clinically during the last four decades, and promising results have been observed more recently with gemcitabine. Although the
Donna S, Shewach, Theodore S, Lawrence
openaire   +2 more sources

Antimetabolites

exaly   +4 more sources